| Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 after treatment I Natsiopoulos, S Intzes, T Liappis, K Zarampoukas, T Zarampoukas, ... Clinical breast cancer 19 (3), 208-215, 2019 | 64 | 2019 |
| Metaplastic breast carcinoma in a patient with Von Recklinghausen's disease I Natsiopoulos, A Chatzichristou, I Stratis, A Skordalaki, N Makrantonakis Clinical Breast Cancer 7 (7), 573-575, 2007 | 29 | 2007 |
| Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease—a prospective study SA Antoniou, P Delivorias, GA Antoniou, I Natsiopoulos, A Kalambakas, ... Langenbeck's archives of surgery 393, 979-984, 2008 | 27 | 2008 |
| Prognostic significance of low HER2 expression in patients with early hormone receptor positive breast cancer G Douganiotis, L Kontovinis, E Markopoulou, A Ainali, T Zarampoukas, ... Cancer diagnosis & prognosis 2 (3), 316, 2022 | 21 | 2022 |
| Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center A Apessos, K Agiannitopoulos, G Pepe, GN Tsaousis, E Papadopoulou, ... Cancer genetics 220, 1-12, 2018 | 18 | 2018 |
| Becker expander-based breast reconstruction following Wise pattern skin-reducing mastectomy: complication rates and risk factors E Demiri, D Dionyssiou, S Sapountzis, L Pavlidis, I Natsiopoulos, ... Aesthetic plastic surgery 41, 304-311, 2017 | 14 | 2017 |
| Clinical utility of functional RNA analysis for the reclassification of splicing gene variants in hereditary cancer K Agiannitopoulos, G Pepe, E Papadopoulou, GN Tsaousis, S Kampouri, ... Cancer Genomics & Proteomics 18 (3), 285-294, 2021 | 8 | 2021 |
| Diffuse breast angiomatosis with involvement of overlying skin: a case report I Natsiopoulos, T Liappis, E Demiri, G Kyropoulos, N Patsinakidis, ... Clinical Breast Cancer 16 (1), e7-e10, 2016 | 7 | 2016 |
| Copy Number Variations (CNVs) account for 10.8% of pathogenic variants in patients referred for hereditary cancer testing K Agiannitopoulos, G Pepe, GN Tsaousis, K Potska, D Bouzarelou, ... Cancer genomics & proteomics 20 (5), 448-455, 2023 | 6 | 2023 |
| Abstract P1-03-08: Different genomic rearrangements account for 17% of BRCA1/2 mutations in Greece A Apessos, E Papadopoulou, V Metaxa-Mariatou, K Agiannitopoulos, ... Cancer Research 75 (9_Supplement), P1-03-08-P1-03-08, 2015 | 3 | 2015 |
| Real-world experience of neoadjuvant chemotherapy for early breast cancer patients: an observational non-interventional study in Thessaloniki, Greece KT Papazisis, T Liappis, L Kontovinis, A Pouptsis, S Intzes, I Natsiopoulus Greece J BUON 25 (2), 634-640, 2020 | 2 | 2020 |
| Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic Testing K Agiannitopoulos, K Potska, A Katseli, C Ntogka, GN Tsaousis, G Pepe, ... Cancers 15 (21), 5218, 2023 | 1 | 2023 |
| Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC)–A phase II study D Tsavdaridis, A Athanasiadis, N Pissanidis, M Saleh, A Moshidis, ... Journal of Clinical Oncology 22 (14_suppl), 3712-3712, 2004 | 1 | 2004 |
| 1709P Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes D Ziogas, K Agiannitopoulos, G Pepe, K Potska, G Tsaousis, ... Annals of Oncology 33, S1321, 2022 | | 2022 |
| Abstract P2-09-10: Different CNVs account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing N Tsoulos, K Agiannitopoulos, G Pepe, E Papadopoulou, GN Tsaousis, ... Cancer Research 82 (4_Supplement), P2-09-10-P2-09-10, 2022 | | 2022 |
| Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries V Kotoula, K Papadopoulou, I Tikas, F Fostira, E Vrettou, S Chrisafi, ... Breast Cancer 28, 1367-1382, 2021 | | 2021 |
| Splicing variants in hereditary cancer genes: clinical utility of functional RNA analysis K Agiannitopoulos, G Pepe, E Papadopoulou, G Tsaousis, S Kampouri, ... EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 538-539, 2020 | | 2020 |
| Somatic involution of pathogenic BRCA1 germline mutations V Kotoula, E Demiri, F Fostira, E Vrettou, K Papadopoulou, I Tikas, ... Cancer Research 78 (13_Supplement), 1359-1359, 2018 | | 2018 |
| Abstract P3-04-04: Germline and somatic mutation status in tissues from BRCA1/2 carriers V Kotoula, E Demiri, F Fostira, E Vrettou, K Papadopoulou, I Tikas, ... Cancer Research 78 (4_Supplement), P3-04-04-P3-04-04, 2018 | | 2018 |
| Genomic features of normal tissues from prophylactic surgery in BRCA1/2 mutation carriers. V Kotoula, E Demiri, F Fostira, E Vrettou, E Charalambous, I Tikas, ... Journal of Clinical Oncology 35 (15_suppl), e13055-e13055, 2017 | | 2017 |
Konstantinos PapazisisEuromedica General Clinic ThessalonikiGeverifieerd e-mailadres voor oncomedicare.com
